Mar 26, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me Opus Genetics has announced vision improvements for the first three adult patients in its Phase ½ gene therapy clinical trial for Leber congenital amaurosis 5 (LCA5), a rare,...
Feb 21, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me The biotechnology company is preparing to launch a pivotal, Phase 3 clinical trial in the US for its emerging jCell therapy. The company’s announcement came after a successful...
Feb 9, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me Beacon Therapeutics has reported vision improvements for five of eight patients receiving the high dose of its X-linked retinitis pigmentosa (XLRP) gene therapy in the Phase 2...
Feb 1, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me Ascidian Therapeutics has received authorization from the US Food & Drug Administration to launch a Phase ½ clinical trial for ACDN-01, the company’s RNA editing therapy for...
Nov 8, 2023 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me Kiora Pharmaceuticals has announced some vision restoration for participants in ABACUS-1, its Phase ½ clinical trial in Australia for KIO-301, a molecule designed to bestow light...
